Compile Data Set for Download or QSAR
Report error Found 87 Enz. Inhib. hit(s) with all data for entry = 11831
TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651863BDBM651863(US20240051956, Example 11)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651862BDBM651862(US20240051956, Example 49)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651865BDBM651865(US20240051956, Example 12)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651864BDBM651864(US20240051956, Example 50)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651859BDBM651859(US20240051956, Example 9)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651858BDBM651858(US20240051956, Example 47)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651861BDBM651861(US20240051956, Example 10)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651860BDBM651860(US20240051956, Example 48)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651870BDBM651870(US20240051956, Example 53)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651872BDBM651872(US20240051956, Example 54)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651867BDBM651867(US20240051956, Example 13)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651866BDBM651866(US20240051956, Example 51)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651869BDBM651869(US20240051956, Example 14)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651868BDBM651868(US20240051956, Example 52)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651847BDBM651847(US20240051956, Example 3)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651848BDBM651848(US20240051956, Example 42)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651843BDBM651843(Synthetic Processes to Prepare Intermediates | US2...)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651845BDBM651845(US20240051956, Example 2)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651844BDBM651844(US20240051956, Example 40)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651855BDBM651855(US20240051956, Example 7)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651854BDBM651854(US20240051956, Example 45)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651857BDBM651857(US20240051956, Example 8)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651856BDBM651856(US20240051956, Example 46)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651851BDBM651851(US20240051956, Example 5)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651850BDBM651850(US20240051956, Example 43)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651853BDBM651853(US20240051956, Example 6)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651852BDBM651852(US20240051956, Example 44)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651896BDBM651896(US20240051956, Example 66)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651903BDBM651903(US20240051956, Example 31)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651902BDBM651902(US20240051956, Example 69)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651905BDBM651905(US20240051956, Example 32)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651904BDBM651904(US20240051956, Example 70)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651899BDBM651899(US20240051956, Example 29)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651901BDBM651901(US20240051956, Example 30)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651900BDBM651900(US20240051956, Example 68)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651879BDBM651879(US20240051956, Example 19)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651878BDBM651878(US20240051956, Example 57)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651881BDBM651881(US20240051956, Example 20)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651880BDBM651880(US20240051956, Example 58)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651875BDBM651875(US20240051956, Example 17)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651874BDBM651874(US20240051956, Example 55)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651877BDBM651877(US20240051956, Example 18)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651876BDBM651876(US20240051956, Example 56)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651886BDBM651886(US20240051956, Example 61)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651883BDBM651883(US20240051956, Example 21)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651882BDBM651882(US20240051956, Example 59)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651927BDBM651927(US20240051956, Example 85)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651926BDBM651926(US20240051956, Example 84)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651923BDBM651923(US20240051956, Example 81)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 651922BDBM651922(US20240051956, Example 80)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

Displayed 1 to 50 (of 87 total ) | Next | Last >>
Jump to: